Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study

• Nele Claes ,

  Contributed equally to this work with: Nele Claes, Tessa Dhaeze

  Affiliation Hasselt University, Biomedical Research Institute and Transnationale Universiteit Limburg, School of Life Sciences, Diepenbeek, Belgium

  ⨯
• Tessa Dhaeze ,

  Contributed equally to this work with: Nele Claes, Tessa Dhaeze

  Affiliation Hasselt University, Biomedical Research Institute and Transnationale Universiteit Limburg, School of Life Sciences, Diepenbeek, Belgium

  ⨯
• Judith Fraussen,

  Affiliation Hasselt University, Biomedical Research Institute and Transnationale Universiteit Limburg, School of Life Sciences, Diepenbeek, Belgium

  ⨯
• Bieke Broux,

  Affiliation Hasselt University, Biomedical Research Institute and Transnationale Universiteit Limburg, School of Life Sciences, Diepenbeek, Belgium

  ⨯
• Bart Van Wijmeersch,

  Affiliations Hasselt University, Biomedical Research Institute and Transnationale Universiteit Limburg, School of Life Sciences, Diepenbeek, Belgium, Rehabilitation & MS-Center, Overpelt, Belgium

  ⨯
• Piet Stinissen,

  Affiliation Hasselt University, Biomedical Research Institute and Transnationale Universiteit Limburg, School of Life Sciences, Diepenbeek, Belgium

  ⨯
• Raymond Hupperts,

  Affiliations Department of Neuroscience, School of Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands, Department of Neurology, Orbis Medical Center, Sittard, The Netherlands

  ⨯
• Niels Hellings,

  Affiliation Hasselt University, Biomedical Research Institute and Transnationale Universiteit Limburg, School of Life Sciences, Diepenbeek, Belgium

  ⨯
• Veerle Somers

  * E-mail: veerle.somers@uhasselt.be

  Affiliation Hasselt University, Biomedical Research Institute and Transnationale Universiteit Limburg, School of Life Sciences, Diepenbeek, Belgium

  ⨯